Culturing Leukemic Blasts with Therapeutics
Corresponding Organization :
Other organizations : The San Raffaele Telethon Institute for Gene Therapy, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, Institute of Biomedical Technologies, National Research Council
Variable analysis
- IACS-010759 concentration (30 nM)
- Cytarabine concentration (100 ng/ml)
- Cell viability/proliferation (measured by flow cytometry)
- Tumor growth/engraftment in recipient NSG mice
- Thawed primary human AML blasts
- Irradiated stromal feeder cell layers
- Cytokine- and SR1-supplemented media
- Magnetic bead-based dead cell removal
- Fresh media addition every 2-3 days
- Cell replatting before reaching 70-80% confluence
- 12 h preconditioning period
- Equivalent volumes of PBS and DMSO for mock-treated conditions
- Positive control: Cytarabine treatment
- Negative control: Mock-treated conditions (DMSO and PBS)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!